D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$392M |
| 2 |
Starbucks
SBUX
|
+$370M |
| 3 |
Pfizer
PFE
|
+$338M |
| 4 |
PayPal
PYPL
|
+$320M |
| 5 |
Charles Schwab
SCHW
|
+$305M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$415M |
| 4 |
Citigroup
C
|
+$312M |
| 5 |
Booking.com
BKNG
|
+$289M |
Sector Composition
| 1 | Technology | 19.01% |
| 2 | Consumer Discretionary | 12.74% |
| 3 | Financials | 11.39% |
| 4 | Healthcare | 11.24% |
| 5 | Energy | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Myers Industries
MYE
$587M
| $453K | ﹤0.01% |
+20,989
| New | +$453K |
|
3102
National CineMedia
NCMI
$455M
| $451K | ﹤0.01% |
17,764
+6,077
| +52% | +$154K |
|
3103
Restaurant Brands International
QSR
$20.6B
| $451K | ﹤0.01% |
7,719
-164
| -2% | -$9.58K |
|
|
PLXP
3104
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $451K | ﹤0.01% |
+111,625
| New | +$451K |
|
|
MBSC
3105
DELISTED
M3-Brigade Acquisition III Corp.
MBSC
| $450K | ﹤0.01% |
45,200
+200
| +0.4% | +$1.99K |
|
|
MLGO
3106
MicroAlgo
MLGO
$97.2M
| $449K | ﹤0.01% |
7
| – | – |
|
3107
Franklin Covey
FC
$240M
| $448K | ﹤0.01% |
9,899
-7,195
| -42% | -$326K |
|
|
DALS
3108
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
| $448K | ﹤0.01% |
45,992
+2,300
| +5% | +$22.4K |
|
3109
Kulicke & Soffa
KLIC
$2.01B
| $447K | ﹤0.01% |
7,975
+4,201
| +111% | +$235K |
|
3110
Annexon
ANNX
$266M
| $446K | ﹤0.01% |
+163,379
| New | +$446K |
|
3111
Red Robin
RRGB
$121M
| $446K | ﹤0.01% |
26,437
-93,581
| -78% | -$1.58M |
|
|
HLGN
3112
DELISTED
Heliogen, Inc.
HLGN
| $446K | ﹤0.01% |
+2,424
| New | +$446K |
|
|
MMX
3113
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $444K | ﹤0.01% |
92,587
+47,910
| +107% | +$230K |
|
3114
Mustang Bio
MBIO
$11.4M
| $443K | ﹤0.01% |
584
+175
| +43% | +$133K |
|
3115
Dave Inc
DAVE
$3.1B
| $442K | ﹤0.01% |
1,930
-8,951
| -82% | -$2.05M |
|
3116
Cambium Networks
CMBM
$20.4M
| $439K | ﹤0.01% |
18,566
+4,334
| +30% | +$102K |
|
3117
DoubleVerify
DV
$2.13B
| $438K | ﹤0.01% |
+17,401
| New | +$438K |
|
3118
Ezcorp Inc
EZPW
$1.04B
| $436K | ﹤0.01% |
72,162
-19,096
| -21% | -$115K |
|
3119
Enanta Pharmaceuticals
ENTA
$177M
| $435K | ﹤0.01% |
6,105
-18,403
| -75% | -$1.31M |
|
3120
Horizon Bancorp
HBNC
$833M
| $434K | ﹤0.01% |
23,224
-15,552
| -40% | -$291K |
|
3121
Scansource
SCSC
$974M
| $433K | ﹤0.01% |
12,454
-15,622
| -56% | -$543K |
|
3122
Beyond Air
XAIR
$12.7M
| $433K | ﹤0.01% |
3,237
-287
| -8% | -$38.4K |
|
3123
Telecom Argentina
TEO
$3.07B
| $432K | ﹤0.01% |
71,803
+45,656
| +175% | +$275K |
|
3124
Quantum Corp
QMCO
$98M
| $430K | ﹤0.01% |
9,475
+506
| +6% | +$23K |
|
3125
FNB Corp
FNB
$5.89B
| $429K | ﹤0.01% |
34,446
-415,049
| -92% | -$5.17M |
|